Numinus Wellness Inc. provides psychedelic-assisted therapy training, lab testing, and psychotherapy services in Canada and the United States. The company operates through Clinical Research Operations and Practitioner Training segments. It also provides clinical research management services to academic institutions and biotechnology companies. In addition, the company engages in the provision of education and training for research and drug development organizations to support clinical trials and commercialization efforts. Numinus Wellness Inc. is headquartered in Vancouver, Canada.
Frequently asked questions
What sector does Numinus Wellness Inc (NUMI) operate in?
Numinus Wellness Inc belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is Numinus Wellness Inc (NUMI) current stock price?
As of the latest data, Numinus Wellness Inc stock price is CA$0.05, with a previous close of CA$0.05.
What is Numinus Wellness Inc (NUMI) current market capitalization?
Numinus Wellness Inc market cap is approximately 16.03 million.
What is Numinus Wellness Inc (NUMI) Earnings Per Share (EPS)?
The trailing EPS is -CA$0.08.
Does Numinus Wellness Inc (NUMI) pay dividends?
No. Numinus Wellness Inc does not pay a dividend.
What is Numinus Wellness Inc (NUMI) beta (volatility) score?
Numinus Wellness Inc has a beta of 2.433, indicating very high volatility compared to the market.